Ann M Doust

No ORCID on file · 2 papers in corpus

other 2024

Clinical predictors of treatment response to gabapentin in women with unexplained chronic pelvic pain

Frontiers in pharmacology ·doi:10.3389/fphar.2024.1460206

INTRODUCTION: Chronic pelvic pain affects up to 24% of women worldwide and for up to 55% of these there is no associated pathology. Despite this there are no established treatments in this cohort. This is a secondary analysis of a randomise…

rct 2020

Gabapentin for chronic pelvic pain in women (GaPP2): a multicentre, randomised, double-blind, placebo-controlled trial

Lancet (London, England) ·doi:10.1016/s0140-6736(20)31693-7

BACKGROUND: Chronic pelvic pain affects 2-24% of women worldwide and evidence for medical treatments is scarce. Gabapentin is effective in treating some chronic pain conditions. We aimed to measure the efficacy and safety of gabapentin in w…